Medication info
Acrab Tablets 60/40 Milligrams

Acrab Tablets 60/40 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›150mg / 1 tabletAtorvastatin Calcium Trihydrate›43.4mg / 1 tablet
Manufacturer / importer
Boryung Co., Ltd.
Appearance
Light orange round film-coated tablet
Packaging
For domestic use - 30 tablets/box [(10 tablets/PTP*3)]
Approval status
Active

MFDS item code 202300720 · Approved 2023.02.28 · Insurance code 641908250

Summary

Main use
Treatment of essential hypertension, improvement of hyperlipidemia, prevention of cardiovascular disease
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, fimasartan and atorvastatin. Patients taking fimasartan and atorvastatin as separate medicines may switch to this medicine (a fixed-dose combination with the same amount of each active ingredient) for convenience. ○ Fimasartan 1. Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take it at the same time every day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, the recommended initial dose of this medicine is 30 mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate ~ severe hepatic impairment. 5. Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. ○ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: Efficacy and safety in elderly patients 70 years of age or older are generally similar to those in the general adult patient population.

Ingredients

Manufacturer
Boryung Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of hyperlipidemia, prevention of cardiovascular disease

  • Essential hypertension
  • myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
View approved original text

This medication is used for patients who require simultaneous administration of Pimasartan and Atorvastatin. Pimasartan is primarily used to treat essential hypertension. Atorvastatin calcium plays a role in reducing the risk of cardiovascular diseases. It reduces the risk of myocardial infarction, stroke, and vascular interventions in adults with multiple cardiovascular risk factors and also helps reduce the risk of myocardial infarction and stroke in patients with type 2 diabetes. Additionally, it lowers the risk of various cardiovascular events and angina and hospitalizations due to congestive heart failure in patients with coronary heart disease. It is also effective for treating dyslipidemia by lowering cholesterol and triglyceride levels and increasing HDL cholesterol levels.

How to take

Adult dose

Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, fimasartan and atorvastatin. Patients taking fimasartan and atorvastatin as separate medicines may switch to this medicine (a fixed-dose combination with the same amount of each active ingredient) for convenience. ○ Fimasartan 1. Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take it at the same time every day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, the recommended initial dose of this medicine is 30 mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate ~ severe hepatic impairment. 5. Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. ○ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: Efficacy and safety in elderly patients 70 years of age or older are generally similar to those in the general adult patient population.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, particularly during the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients with impaired liver function, muscle disorders, or certain genetic lactose intolerance. If symptoms of muscle pain or weakness occur during treatment, consult a doctor immediately, and discontinue treatment if severe. Blood pressure may drop too low, so patients with low blood volume or salt depletion should be monitored closely at the start of treatment. This medication may have side effects such as liver dysfunction, headaches, dizziness, fatigue, and edema, so report any worsening symptoms to a doctor. Since there are many drug interactions, inform healthcare providers of any other medications being taken, and caution is advised when used with certain antibiotics, antifungals, and HIV treatments. Women of childbearing potential should use appropriate contraception while taking this medication, and nursing mothers should avoid its use or discontinue breastfeeding. It is advisable not to use this medication in children or in pediatric patients under 10 years of age, as safety and efficacy have not been established. Elderly patients may be more sensitive to this medication, so extra caution should be taken during use. In the case of overdose, symptoms such as hypotension or cardiac arrhythmias may occur, and appropriate treatment should be given if necessary. This medication should be stored out of reach of children in its original container, as transferring it to another container may risk deterioration or misuse.

Side effects

  • Headache
  • dizziness
  • increased serum creatine phosphokinase
  • abnormal liver enzyme levels
  • increased ALT
  • elevated lactate dehydrogenase
  • elevated liver enzyme levels
  • hypokalemia
  • fatigue
  • edema
Show 216 more
  • myalgia
  • hypertension
  • ventricular extrasystole
  • syncope
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • decreased platelet count
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • hair loss
  • vascular edema
  • angioedema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • loss of appetite
  • constipation
  • abdominal distension
  • diarrhea
  • pharyngolaryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • sensory abnormality
  • sensory decline
  • taste disturbance
  • memory loss
  • peripheral neuropathy
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • anaphylaxis
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • hepatitis
  • cholestatic jaundice
  • abnormal liver function test values
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial dizziness
  • bronchitis
  • pneumonia
  • dyspnea
  • asthma
  • pulmonary granulomatosis
  • abnormal chest X-ray findings
  • bronchitis
  • sputum
  • bronchitis
  • pneumonia
  • lung disease
  • hemoptysis
  • exacerbation of rhinitis
  • interstitial pneumonia
  • asthma
  • pulmonary granulomatosis
  • abnormal chest X-ray findings
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • acute renal failure
  • chronic renal failure
  • nephrolithiasis
  • pyelonephritis
  • urinary incontinence
  • frequency of urination
  • exacerbation of chronic renal failure
  • cystitis
  • urinary tract infection
  • increased BUN
  • pyelonephritis
  • otitis media
  • fungal infection
  • abscess
  • bacterial infection
  • genital herpes
  • herpes labialis
  • shingles
  • colorectal cancer
  • neoplasm of uncertain behavior
  • liver cancer
  • cervical cancer
  • prostate cancer
  • panic response
  • Alzheimer's disease
  • suicide attempt
  • anxiety
  • insomnia
  • depression
  • hyperthyroidism
  • hypothyroidism
  • increased TSH
  • benign pituitary neoplasm
  • atrial fibrillation
  • bradycardia
  • arrhythmia
  • tachycardia
  • coronary artery disease
  • arterial stenosis
  • aortic stenosis
  • angina
  • myeloproliferative disorders
  • worsening of anemia
  • iron deficiency anemia
  • tinnitus
  • hearing impairment
  • deafness
  • pelvic inflammatory disease
  • vaginitis
  • uterine prolapse
  • prostatic hyperplasia
  • scrotal pain
  • heart failure
  • blood pressure fluctuations
  • increased blood pressure
  • purpura
  • fatty liver
  • localized inflammation
  • soft tissue inflammation
  • pulmonary embolism
  • lymphadenopathy
  • wound
  • septal deviation
  • surgical intervention
  • postoperative pain
  • heat intolerance
  • recurrent cancer
  • falls
  • postoperative pain
  • chest pain
  • back pain
  • limb pain
  • facial swelling
  • fever
  • neck and shoulder pain
  • fracture
  • arthralgia
  • osteoporosis
  • muscle weakness
  • sensory abnormalities
  • numbness
  • tremors
  • hypertonicity
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • functional dyspepsia
  • gastroenteritis
  • frequency of urination
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • increased blood pressure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture and should be stored in a tightly sealed container. It is also best to keep the medication at room temperature, between 1 and 30 degrees Celsius, away from very hot or very cold places.

Appearance and packaging

Appearance

Light orange round film-coated tablet

Package unit

For domestic use - 30 tablets/box [(10 tablets/PTP*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.